Safety and efficacy of video-assisted versus conventional lung resection for lung cancer

Farjah, Farhood; Wood, Douglas E.; Mulligan, Michael S.; Krishnadasan, Bahirathan; Heagerty, Patrick J.; Symons, Rebecca; Flum, David R.

doi:10.1016/j.jtcvs.2008.11.035

Cited by 81 publications

(50 citation statements)

References 28 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Based on data from a prospective, randomized trial, Sugi et al [44] found no difference in the 3-and 5-year survival rates after VATS versus conventional lobectomy for stage IA NSCLC (90% versus 93% at 3 years and 90% versus 85% at 5 years). Several other studies were in accordance with these results, and the 5-year survival for VATS lobectomy was near 80% [51][52][53]; similar to that for traditional open procedures (75% to 82%).…”

Section: Long-term Outcomesupporting

confidence: 77%

Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer

Zhu

Chen

2011

Front. Med.

View full text Add to dashboard Cite

Video-assisted thoracoscopic surgery (VATS) provides a new approach for treating early-stage lung cancer. Lobectomy by VATS has many advantages over conventional thoracotomy, such as shorter recovery time, less postoperative pain, and faster resumption of a normal lifestyle. However, there is still much debate on the role of VATS in lobectomy for the treatment of lung cancer. Concerns regarding safety, the extent of mediastinal lymph node dissection, and long-term survival have made some surgeons apprehensive of its validity for lung cancer. In this paper, we review the development of thoracoscopy, the present status of VATS for early stage of non-small cell lung cancer (NSCLC), and comparison between VATS and open thoracotomy in the management of NSCLC.

show abstract

Section: Long-term Outcomesupporting

confidence: 77%

Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer

Zhu

Chen

2011

Front. Med.

View full text Add to dashboard Cite

show abstract

“…Standard curative treatment for patients with resectable NSCLC is lobectomy by video-assisted thoracoscopic surgery 79 . This minimally invasive approach can reduce postoperative morbidity and duration of hospitalization, but eligibility depends on the individual patient, the location of the tumour and the expertise of the centre.…”

Section: Resectable Nsclcmentioning

confidence: 99%

Non-small-cell lung cancer

Gridelli

Rossi

Carbone

et al. 2015

Nat Rev Dis Primers

746

621

View full text Add to dashboard Cite

“…It has been reported that there was a nine-fold increase in the utilization of VATS from the mid 90's the early 21st century and this trend appears to be increasing as the skill and experience at high volume institutions continues to increase (17). Prior series have shown VATS to be equivalent or better than conventional thoracotomy in terms of operative morbidity and mortality (4).…”

Section: Discussionmentioning

confidence: 99%

Prospective study of quality of life after lung cancer resection

Hopkins¹,

Ferson²,

Shende³

et al. 2017

Ann. Transl. Med.

View full text Add to dashboard Cite

Background: Surgical resection with curative-intent remains the gold standard for clinically operable early-stage non-small cell lung cancer (NSCLC). This goal can be accomplished using a minimally invasive option, e.g., video assisted thoracic surgery (VATS) or standard thoracotomy. Surgical techniques continue to evolve and few studies have compared the QOL of patients managed with these procedures using current approaches. The primary goal of this study was to investigate differences between patients managed surgically via VATS compared to thoracotomy with respect to ratings of chronic pain, anxiety/depression and quality of life (QOL). The secondary goal was to investigate differences between patients converted from VATS to thoracotomy versus those managed with the originally with thoracotomy.Methods: We conducted a prospective cross sectional design study comparing the QOL after surgical resection of NSCLC. Data were obtained between 3-12 months postoperatively, from patients with potentially resectable stage I-IIIa NSCLC, who underwent a thoracotomy or VATS resection. All patients were consented. Pain was evaluated with a 0 to 10 numeric pain assessment scale (NAS), mood with the Hospital Anxiety and Depression Scale (HADS) (mood disorders) and QOL with FACT-L (Functional Assessment of Cancer Therapy-Lung).Results: A total of 97 patients with stage I-IIIa lung cancer were enrolled; of these 66 (68%) underwent a standard thoracotomy and 31 (32%) underwent VATS resection. The preferred surgical approach was a thoracotomy for patients with stage IIIa lung cancer, or patients requiring a pneumonectomy or a bi-lobectomy. There were no significant differences between VATS and thoracotomy patients in ratings of chronic pain, mood disorders, or QOL. Conversion from VATS to thoracotomy occurred in 22 (23%) of patients. There were no significant differences between VATS conversion to thoracotomy and those with initial thoracotomy procedures in ratings of chronic pain, mood disorders, or QOL. Conversion from VATS to standard thoracotomy occurred more commonly early in the series.Conclusions: While previous studies have shown that VATS offers an early advantage with regards to perioperative outcomes, our study demonstrated that VATS and thoracotomy patients had similar late QOL outcomes.

show abstract

Safety and efficacy of video-assisted versus conventional lung resection for lung cancer

Abstract: Video-assisted thoracoscopy was uncommonly used to manage lung cancer, although its use has increased over time. Video-assisted thoracoscopy and conventional resection were equivalent in terms of long-term survival.

Cited by 81 publications

References 28 publications

Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer

Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer

Non-small-cell lung cancer

Prospective study of quality of life after lung cancer resection

Contact Info

Product

Resources

About